BWAY.NASDAQBrainsway LTD

Form 4: Brainsway Ltd. Director Reports Share Transactions

Sentiment:

Statement of Changes in Beneficial Ownership


Brainsway Ltd. director Rayten Michal Mitrany reported transactions involving the acquisition and disposition of ordinary shares and stock options.

Summary

  • Rayten Michal Mitrany, a Director of Brainsway Ltd., reported several transactions on May 19th and May 20th, 2026.
  • On May 19th, 2026, 10,000 ordinary shares were acquired (Transaction Code M), increasing the total directly held shares to 22,500.
  • Also on May 19th, 3,440 ordinary shares were disposed of (Transaction Code F), leaving 19,060 shares.
  • On May 20th, 2026, an additional 17,500 ordinary shares were acquired (Transaction Code M), bringing the total directly held shares to 36,560.
  • On May 20th, 2026, 6,080 ordinary shares were disposed of (Transaction Code F), leaving 30,480 shares.
  • The filing also details the exercise of stock options. On May 19th, 10,000 stock options were exercised (Transaction Code M), with an exercise price of NIS 15.26 per share.
  • On May 20th, 17,500 stock options were exercised (Transaction Code M), also with an exercise price of NIS 15.26 per share.
  • The stock options were originally granted on January 13, 2020, and were fully vested by November 28, 2023.
  • Some shares were retained by the Company to cover the exercise price of the stock options, at prices of NIS 44.36 and NIS 43.92 per share respectively.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports standard insider transactions, with a mix of acquisitions (via option exercise) and dispositions, without clear indication of strong positive or negative sentiment beyond the typical exercise of vested options.

Positives

  • Director Rayten Michal Mitrany acquired a net of 27,500 ordinary shares through option exercises.
  • The exercise of stock options indicates a belief in the company's value, as the exercise price is significantly lower than the retention price for shares used to cover the exercise cost (NIS 15.26 vs. NIS 44.36/43.92).

Negatives

  • A total of 9,520 ordinary shares were disposed of (3,440 on May 19th and 6,080 on May 20th).
  • The company retained a significant number of shares (3,440 + 6,080 = 9,520) to cover the exercise price of stock options, indicating a cash outflow or share dilution for the director.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The exercise of stock options and subsequent retention of shares to cover costs are common practices, but the specific prices and volumes can offer insights into insider sentiment regarding the stock's valuation.

Stakeholder Impact

  • Shareholders: The transactions may slightly increase the number of shares outstanding if options are exercised and new shares are issued, or reflect a director managing their personal holdings. The retention of shares to cover exercise costs could be viewed as a minor dilution event.

Key Dates

DateDescription
01/13/2020Date stock options were granted.
11/28/2023Date stock options were fully vested.
05/19/2026Earliest transaction date reported; acquisition and disposition of ordinary shares and exercise of stock options.
05/20/2026Date of further acquisition and disposition of ordinary shares and exercise of stock options.
05/21/2026Date of signature on the filing.

Keywords

Brainsway Ltd., BWAY, Form 4, SEC Filing, Insider Trading, Stock Options, Ordinary Shares, Beneficial Ownership, Director Transactions, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.